One thousand five hundred seventy-nine men with intermediate-risk prostate cancer were randomly assigned to 8 weeks of AS followed by radiotherapy with an additional 8 weeks of concurrent AS ( 16 weeks total ) or to 28 weeks of AS followed by radiotherapy with an additional 8 weeks of AS ( 36 weeks total ) .